Failed biotechs tout cash to attract buyers
Saturday, September 27, 2008 - 09:35
in Mathematics & Economics
BOSTON (Reuters) - Small biotechnology companies with cash but failed or floundering products are in hot demand as partners for companies that are unable to raise money in the capital markets.